BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31304554)

  • 1. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
    Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
    Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus.
    Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
    Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
    Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
    JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review.
    Rajendra S; Pavey D; McKay O; Merrett N; Gautam SD
    Ann N Y Acad Sci; 2020 Dec; 1482(1):36-48. PubMed ID: 33103249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: is HPV the common denominator?
    Rajendra S; Robertson IK
    J Clin Pathol; 2010 Jan; 63(1):1-3. PubMed ID: 20026700
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
    Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
    Odze RD; Lauwers GY
    Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A-p16 Deletion and Activated KRAS
    Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.
    Zeki SS; Haidry R; Graham TA; Rodriguez-Justo M; Novelli M; Hoare J; Dunn J; Wright NA; Lovat LB; McDonald SA
    Am J Gastroenterol; 2013 Oct; 108(10):1584-92. PubMed ID: 23939625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.